Fagron NV (FAGR) | Stock Overview & Key Data
Fagron NV Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €41.80 on August 4, 2014
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fagron NV
FAGR
|
1.73B Large-cap | 2.31% | 0.00% | 11.19% | 17.92% | 11.95% | 13.01% | 57.64% | 25.06% | 247.12% | 93.51% | 93.51% |
| N/A | -1.22% | 14.47% | 5.09% | 6.07% | 7.58% | 85.71% | 225.88% | 200.37% | 364.29% | 681.77% | 681.77% | |
|
UCB S.A
UCB
|
50.14B Large-cap | -0.69% | 9.37% | 1.69% | 8.86% | 10.67% | 68.19% | 220.47% | 222.73% | 332.23% | 618.13% | 618.13% |
|
Argenx SE
ARGX
|
41.43B Large-cap | -0.26% | 9.81% | 24.18% | 24.18% | 24.18% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% |
|
Ion Beam
IBAB
|
411.94M Mid-cap | -0.25% | 11.42% | 12.66% | 35.68% | 25.00% | 38.30% | 1.44% | 0.00% | -56.09% | 275.56% | 275.56% |
|
Onward Medical N.V
ONWD
|
204.41M Mid-cap | -3.62% | -3.97% | -26.92% | -34.00% | -39.41% | -37.17% | -55.89% | -79.43% | -79.43% | -79.43% | -79.43% |
Ownership & Short Interest
Calculate Your Fagron NV Investment Returns
Long-Term Investment Performance Analysis
Fagron NV stock price in Jul 2016 was €7.40, A €1,000.00 lump sum investment in Fagron NV made 9 years ago would be worth approximately €3,290.54 today, representing a outstanding return of 229.05%. This translates to an annualized return (CAGR) of 12.77%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is FAGR's 52-week high and low?
- In the last 52 weeks, Fagron NV reached a high of €25.30 (on May 27, 2026) and a low of €19.24 (on September 18, 2025).
- What is the market cap and P/E ratio for FAGR?
- Curious about Fagron NV's size and valuation? Its market capitalization stands at 1.73B. When it comes to valuation, the P/E ratio (trailing twelve months) is 19.15, and the forward P/E (looking ahead) is 14.43.
- Does FAGR pay dividends? If so, what's the yield?
- Yes, Fagron NV is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.60%, and the company has paid an average of €0.30 per share annually over the past 3 years.
- Who are Fagron NV's main competitors or similar companies to consider before investing?
When looking at Fagron NV, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Financière de Tubize
TUBN/A Healthcare Biotechnology 85.71% 225.88% UCB S.A
UCB50.14B Healthcare Biotechnology 68.19% 220.47% Argenx SE
ARGX41.43B Healthcare Biotechnology 29.01% 29.01% Ion Beam
IBAB411.94M Healthcare Medical Devices 38.30% 1.44% Onward Medical N.V
ONWD204.41M Healthcare Biotechnology -37.17% -55.89% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Fagron NV? (e.g., ROE, Debt/Equity)
- To get a sense of Fagron NV's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.24%, the Debt to Equity ratio from the most recent quarter is 84.34, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for FAGR?
- Looking at Fagron NV's growth, its revenue over the trailing twelve months (TTM) was €952M. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.60%, and quarterly earnings saw a YoY growth of 13.30%.
- How much of FAGR stock is held by insiders and institutions?
- Wondering who owns Fagron NV stock? Company insiders (like executives and directors) hold about 0.30% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 67.28%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.